Both these, 1 & 2, are about the results in a study over Gilead's & ViiV's 2-drug, once monthly injection for HIV. The injection consists of Cabotegravir, a new, long lasting med & Rilpivirine. The 1st drug is a manufactured by Gilead & ViiV, the 2nd by Gilead & Johnson & Johnson.
The article states the injection has suppression rates as good as 3 med oral regimens. They specifically mentioned Triumeq. I'm sure there will be complications with the injection & possible interactions, it's a medication. But if not too severe, this could be a game changer for a lot of people. It would make filing insurance simpler. It's a lot easier to remember a once monthly shot as compared to a daily pill. This could be big.
Cya...
No comments:
Post a Comment